Filing Details

Accession Number:
0001213900-23-029901
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-14 16:19:42
Reporting Period:
2023-04-14
Accepted Time:
2023-04-14 16:19:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1788028 Jasper Therapeutics Inc. JSPR Biological Products, (No Disgnostic Substances) (2836) 842984849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1871871 Louise Anna French C/O Jasper Therapeutics, Inc.
2200 Bridge Pkwy, Suite #102
Redwood City CA 94065
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Disposition 2023-04-14 7,000 $1.48 23,750 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold by the Reporting Person solely in order to satisfy certain tax obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.